Combining Innovation and Speed
Abstract: Particle size plays a critical role in the performance of poorly soluble, highly potent, and inhaled drug products. This article explores how a science-driven micronization strategy can help enhance bioavailability, achieve consistent dose delivery, and accelerate development while maintaining the quality and scalability needed for clinical and commercial success. Learn how specialized particle engineering expertise, robust containment capabilities, and integrated development support can help overcome complex formulation challenges and streamline the path to patients.